Natixis Advisors LLC Raises Position in Corteva, Inc. $CTVA

Natixis Advisors LLC grew its position in Corteva, Inc. (NYSE:CTVA) by 3.3% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 657,702 shares of the company’s stock after buying an additional 21,075 shares during the period. Natixis Advisors LLC’s holdings in Corteva were worth $44,086,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of CTVA. JPL Wealth Management LLC bought a new position in Corteva during the third quarter valued at approximately $25,000. Redmont Wealth Advisors LLC bought a new position in Corteva during the third quarter valued at approximately $29,000. Jackson Grant Investment Advisers Inc. lifted its position in Corteva by 90.6% during the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock valued at $30,000 after purchasing an additional 213 shares during the period. Basepoint Wealth LLC bought a new position in Corteva during the fourth quarter valued at approximately $30,000. Finally, KERR FINANCIAL PLANNING Corp bought a new position in Corteva during the third quarter valued at approximately $33,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Wall Street Zen downgraded shares of Corteva from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. The Goldman Sachs Group increased their price objective on shares of Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a research report on Tuesday, April 14th. Royal Bank Of Canada increased their price objective on shares of Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a research report on Thursday, May 7th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Corteva from $90.00 to $100.00 in a research report on Monday, May 11th. Finally, Jefferies Financial Group increased their price objective on shares of Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $88.67.

Corteva Stock Up 0.5%

Shares of CTVA stock opened at $77.93 on Thursday. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $85.63. The stock has a market cap of $52.12 billion, a P/E ratio of 45.84, a P/E/G ratio of 2.37 and a beta of 0.57. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. The company has a 50 day simple moving average of $81.33 and a two-hundred day simple moving average of $74.84.

Corteva (NYSE:CTVA) last announced its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same period in the prior year, the company earned $1.13 earnings per share. The firm’s revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s dividend payout ratio is currently 42.35%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.